Workflow
ET.RES.ACQ(ERESW)
icon
Search documents
ET.RES.ACQ(ERESW) - 2025 Q3 - Quarterly Report
2025-11-07 21:02
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) (S ...
ET.RES.ACQ(ERESW) - 2025 Q3 - Quarterly Results
2025-11-06 22:03
Financial Performance - Total revenue for Q3 2025 reached $63.0 million, representing a 124% increase year-over-year from $28.1 million[3] - GAAP net income attributable to shareholders was $7.1 million, a significant recovery from a net loss of $5.1 million in the prior-year period[3] - Adjusted net income increased 60% year-over-year to $23.6 million, compared to $14.7 million in the prior year[3] - Adjusted EBITDA grew 127% year-over-year to $37.9 million, with an adjusted EBITDA margin of 60.2%[3] - Total revenues for Q3 2025 reached $62.98 million, a significant increase from $28.15 million in Q3 2024, representing a growth of 123.7% year-over-year[22] - Life solutions revenue surged to $45.54 million in Q3 2025, compared to $28.03 million in Q3 2024, marking a 62.6% increase[22] - Gross profit for Q3 2025 was $55.32 million, up from $25.96 million in Q3 2024, reflecting a growth of 113.2%[22] - Operating income for the nine months ended September 30, 2025, was $65.96 million, compared to $15.87 million for the same period in 2024, indicating a year-over-year increase of 314.5%[22] - Net income for Q3 2025 was $7.08 million, a turnaround from a net loss of $5.28 million in Q3 2024[22] - For the three months ended September 30, 2025, Abacus Global Management reported an adjusted net income of $23,608,143, compared to $14,719,496 for the same period in 2024, reflecting a year-over-year increase of 60.5%[23] - The adjusted EBITDA for the three months ended September 30, 2025, was $37,904,835, with an adjusted EBITDA margin of 60.2%, compared to $16,666,306 and a margin of 59.2% in the same period of 2024[25] - Total revenue for the three months ended September 30, 2025, was $62,975,156, up from $28,148,491 in the same period of 2024, indicating a significant growth of 123.5%[25] - For the nine months ended September 30, 2025, the adjusted net income was $54,567,277, compared to $24,118,367 for the same period in 2024, representing an increase of 126.5%[24] Financial Position - Total assets as of September 30, 2025, amounted to $918.94 million, an increase from $874.16 million at the end of 2024, representing a growth of 5.1%[21] - Current liabilities increased to $148.44 million as of September 30, 2025, compared to $62.47 million at the end of 2024, reflecting a 137.5% rise[21] - Cash and cash equivalents decreased to $86.42 million from $131.94 million at the end of 2024, a decline of 34.5%[21] - The company repurchased 6,726,082 shares at a cost of $50.27 million as of September 30, 2025, compared to 1,048,226 shares repurchased for $12.03 million at the end of 2024[21] Returns and Shareholder Value - Annualized return on invested capital (ROIC) for Q3 2025 was 21%, and annualized return on equity (ROE) was 22%[10] - The adjusted annualized return on invested capital (ROIC) for the period ended September 30, 2025, was 21%, slightly up from 20% in the previous year[26] - The adjusted annualized return on equity (ROE) for the period ended September 30, 2025, was 22%, down from 23% in the previous year[27] - Earnings per share for Q3 2025 were $0.07, compared to a loss of $0.07 per share in Q3 2024[22] - The adjusted EPS for the three months ended September 30, 2025, was $0.25 for basic shares, compared to $0.20 in the same period of 2024[23] Strategic Initiatives - Abacus completed the strategic acquisition of AccuQuote, enhancing its financial services platform and expanding client lifecycle coverage[10] - The company announced a $50 million securitized asset-backed rated note of life insurance assets, marking a scalable funding mechanism[10] - Abacus was added to the Russell 2000® and 3000® Indexes, effective September 22, 2025, enhancing visibility to institutional investors[10] Costs and Liabilities - The company incurred business acquisition and special legal costs of $5,941,429 for the three months ended September 30, 2025[25] - The loss on change in fair value of warrant liability was $1,081,193 for the three months ended September 30, 2025, compared to $8,766,500 in the same period of 2024[25]
ET.RES.ACQ(ERESW) - 2025 Q2 - Quarterly Report
2025-08-12 12:59
Table of Contents OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 Delaware 85-1210472 (State or other jurisdiction of incorporation or organization) (I.R.S. Em ...
ET.RES.ACQ(ERESW) - 2025 Q2 - Quarterly Results
2025-08-08 13:12
FORM 8-K __________________ CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 __________________ Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________ 001-39403 (Commission File Number) 85-1210472 (I.R.S. Emp ...
ET.RES.ACQ(ERESW) - 2025 Q1 - Quarterly Report
2025-05-08 21:02
Table of Contents For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Delawa ...
ET.RES.ACQ(ERESW) - 2025 Q1 - Quarterly Results
2025-05-08 20:35
__________________ CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 __________________ Abacus Global Management, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________ FORM 8-K (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Commission File Number) 85-1210472 (I.R.S. Employ ...
ET.RES.ACQ(ERESW) - 2024 Q4 - Annual Report
2025-03-28 21:16
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) (State or o ...
ET.RES.ACQ(ERESW) - 2024 Q3 - Quarterly Report
2024-11-07 21:27
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 85-121 ...
ET.RES.ACQ(ERESW) - 2024 Q3 - Quarterly Results
2024-11-07 21:21
ABACUS LIFE REPORTS THIRD QUARTER 2024 RESULTS Delivered Continued Revenue and Profitability Growth While Executing on Strategic Initiatives - - Third Quarter 2024 Total Revenue Grows 33% Year-over-Year to $28.1 Million - - Due to Non-Cash Increase in Warrant Liability of $8.7M; GAAP Net Loss of $5.1M - - Adjusted Net Income Grows 65% Year-over-Year to $14.9 Million - - Adjusted EBITDA Grows 54% Year-over-Year to $16.7 Million - ORLANDO, Fla. – November 7, 2024 – Abacus Life, Inc. ("Abacus" or the "Company" ...
ET.RES.ACQ(ERESW) - 2024 Q2 - Quarterly Report
2024-08-12 12:40
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 85-1210472 ...